<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>276095</rcn>
  <id>101145768</id>
  <acronym>PREGART</acronym>
  <teaser>PREGART is a multi-national Phase-4 randomized clinical trial aimed at identifying optimal antiretroviral treatment (ART) regimens by comparing the efficacy and safety of dolutegravir- versus low-dose efavirenz (EFV400mg-) based first-line cART regimens in 1156 HIV-infected...</teaser>
  <objective>PREGART is a multi-national Phase-4 randomized clinical trial aimed at identifying optimal antiretroviral treatment (ART) regimens by comparing the efficacy and safety of dolutegravir- versus low-dose efavirenz (EFV400mg-) based first-line cART regimens in 1156 HIV-infected pregnant women and infant pairs in Ethiopia and Uganda. The primary outcomes are undetectable viral load at delivery, prevention of mother-to-child transmission of HIV, and adverse pregnancy outcomes. The COVID-19 pandemic significantly hampered all trial activities, including patient enrollment, follow-up, regulatory approvals, and trial site initiation. All clinical trial activities were suspended to protect the safety of study participants (pregnant women and infants) following the stay-at-home orders during the initial wave (March - September 2020) and intermittently during the subsequent waves of COVID-19. Furthermore, the PREGART trial activity was affected by the civil war in northern Ethiopia (2021/22) and the Ebola disease outbreak in Uganda (2022/23). Efforts have been made to mitigate these challenges by opening new trial sites, adapting protocols, and utilizing decentralized trial approaches to increase the participant recruitment rate. To complete the PREGART clinical trial, we request another 36 months and 1.8 million euros to compensate for time and incurred financial loss due to the COVID-19 pandemic, the civil war in Ethiopia, and the Ebola outbreak in Uganda. Completion of clinical trial activities and data analysis will fulfill our obligation to protect the scientific quality and data integrity, ensuring our commitments to study participants and meet PREGART trial objectives - to provide comprehensive and statistically powered evidence for policymakers on the maternal and infant safety and efficacy of dolutegravir and EFV 400mg containing cART. The study will contribute towards optimizing WHO and regional ART guidelines for HIV-infected pregnant and breastfeeding women.</objective>
  <title>Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women -  a randomized non-inferiority clinical trial</title>
  <totalCost>1800000</totalCost>
  <ecMaxContribution>1800000</ecMaxContribution>
  <startDate>2026-01-01</startDate>
  <endDate>2028-12-31</endDate>
  <ecSignatureDate>2025-08-22</ecSignatureDate>
  <duration>36</duration>
  <status>SIGNED</status>
  <keywords>HIV, Pregnant and breastfeeding women, Pregnancy outcome, Antiretroviral treatment</keywords>
  <identifiers>
    <grantDoi>10.3030/101145768</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-08-26 14:07:18</sourceUpdateDate>
  <contentCreationDate>2025-08-26 16:40:09</contentCreationDate>
  <contentUpdateDate>2025-08-26 16:40:04</contentUpdateDate>
  <lastUpdateDate>2025-09-19 14:48:53</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>56360</rcn>
        <title>HORIZON-JU-GH-EDCTP3-2023-01</title>
        <identifier>HORIZON-JU-GH-EDCTP3-2023-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>56360</rcn>
        <title>HORIZON-JU-GH-EDCTP3-2023-01</title>
        <identifier>HORIZON-JU-GH-EDCTP3-2023-01</identifier>
      </call>
      <organization netEcContribution="100000" totalCost="100000" source="corda" order="2" ecContribution="100000" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1906502</rcn>
        <id>999978821</id>
        <vatNumber>IT03657731000</vatNumber>
        <legalName>ISTITUTO SUPERIORE DI SANITA</legalName>
        <address>
          <street>Viale Regina Elena 299</street>
          <city>Roma</city>
          <postalCode>00161</postalCode>
          <country>IT</country>
          <postBox>N/A</postBox>
          <url>http://www.iss.it</url>
          <geolocation>41.9041416,12.5180731</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Roma</name>
              <rcn>1464004</rcn>
              <nutsCode>ITI43</nutsCode>
              <parents>
                <region>
                  <name>Lazio</name>
                  <rcn>1465012</rcn>
                  <nutsCode>ITI4</nutsCode>
                  <parents>
                    <region>
                      <name>Centro (IT)</name>
                      <rcn>1465008</rcn>
                      <nutsCode>ITI</nutsCode>
                      <parents>
                        <region>
                          <name>Italy</name>
                          <rcn>309758504</rcn>
                          <nutsCode>IT</nutsCode>
                          <euCode>IT</euCode>
                          <isoCode>IT</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Italy</name>
              <rcn>309758504</rcn>
              <nutsCode>IT</nutsCode>
              <euCode>IT</euCode>
              <isoCode>IT</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="600000" totalCost="600000" source="corda" order="4" ecContribution="600000" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1907546</rcn>
        <id>999856601</id>
        <legalName>MAKERERE UNIVERSITY</legalName>
        <shortName>MAKERERE</shortName>
        <address>
          <street>Main Campus</street>
          <city>Kampala</city>
          <postalCode>256</postalCode>
          <country>UG</country>
          <postBox>PO BOX 7072</postBox>
          <geolocation>0.3061347,32.5622473</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Uganda</name>
              <rcn>507677224</rcn>
              <nutsCode>UG</nutsCode>
              <euCode>UG</euCode>
              <isoCode>UG</isoCode>
            </region>
            <region type="relatedRegion">
              <name>Uganda</name>
              <rcn>507677224</rcn>
              <nutsCode>UG</nutsCode>
              <euCode>UG</euCode>
              <isoCode>UG</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="500000" totalCost="500000" source="corda" order="1" ecContribution="500000" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1906240</rcn>
        <id>999978530</id>
        <vatNumber>SE202100297301</vatNumber>
        <legalName>KAROLINSKA INSTITUTET</legalName>
        <shortName>KAROLINSKA INSTITUTE</shortName>
        <address>
          <street>NOBELS VAG 5</street>
          <city>STOCKHOLM</city>
          <postalCode>171 77</postalCode>
          <country>SE</country>
          <postBox>N/A</postBox>
          <url>http://www.ki.se</url>
          <geolocation>59.3481714,18.0250493</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Stockholms län</name>
              <rcn>473436224</rcn>
              <nutsCode>SE110</nutsCode>
              <parents>
                <region>
                  <name>Stockholm</name>
                  <rcn>473436264</rcn>
                  <nutsCode>SE11</nutsCode>
                  <parents>
                    <region>
                      <name>Östra Sverige</name>
                      <rcn>473438760</rcn>
                      <nutsCode>SE1</nutsCode>
                      <parents>
                        <region>
                          <name>Sweden</name>
                          <rcn>473598504</rcn>
                          <nutsCode>SE</nutsCode>
                          <euCode>SE</euCode>
                          <isoCode>SE</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Sweden</name>
              <rcn>473598504</rcn>
              <nutsCode>SE</nutsCode>
              <euCode>SE</euCode>
              <isoCode>SE</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <organization netEcContribution="600000" totalCost="600000" source="corda" order="3" ecContribution="600000" terminated="false" sme="false" type="participant">
        <availableLanguages>en</availableLanguages>
        <rcn>1964202</rcn>
        <id>937711514</id>
        <legalName>HAWASSA UNIVERSITY</legalName>
        <address>
          <street>HAWASSA CITY MISRAK SUB CITY TESSO KEBELE</street>
          <city>Hawassa</city>
          <country>ET</country>
          <geolocation>7.0481029,38.47861</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/HES</code>
              <title>Higher or Secondary Education Establishments</title>
              <displayCode>/Higher or Secondary Education Establishments</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Ethiopia</name>
              <rcn>242649640</rcn>
              <nutsCode>ET</nutsCode>
              <euCode>ET</euCode>
              <isoCode>ET</isoCode>
            </region>
            <region type="relatedRegion">
              <name>Ethiopia</name>
              <rcn>242649640</rcn>
              <nutsCode>ET</nutsCode>
              <euCode>ET</euCode>
              <isoCode>ET</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705741</rcn>
        <id>HORIZON.2.1</id>
        <code>HORIZON.2.1</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.2.1</pga>
        <title>Health</title>
        <parent>
          <programme>
            <rcn>705740</rcn>
            <code>HORIZON.2</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>708384</rcn>
        <id>HORIZON_HORIZON-JU-GH-EDCTP3-2023-01-02</id>
        <code>HORIZON-JU-GH-EDCTP3-2023-01-02</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Funding to successfully finalise EDCTP2-funded clinical trials that were negatively impacted by the COVID-19 pandemic</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450332</code>
              <title>Clinical research</title>
              <displayCode>/Clinical research</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43456393</code>
              <title>Public health</title>
              <displayCode>/Public health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43453510</code>
              <title>Infectious diseases</title>
              <displayCode>/Infectious diseases</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43452784</code>
              <title>Global health</title>
              <displayCode>/Global health</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages>en</availableLanguages>
              <code>/43450338</code>
              <title>Clinical trials</title>
              <displayCode>/Clinical trials</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/121/44109686/56306972</code>
        <title>ebola</title>
        <displayCode>/medical and health sciences/health sciences/infectious diseases/RNA viruses/ebola</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/137/133/9678651</code>
        <title>pandemics</title>
        <displayCode>/medical and health sciences/health sciences/public health/epidemiology/pandemics</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/29/97/67681549/64785222</code>
        <title>revolutions</title>
        <displayCode>/social sciences/political sciences/political transitions/revolutions</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/33/121/44109686/619</code>
        <title>HIV</title>
        <displayCode>/medical and health sciences/health sciences/infectious diseases/RNA viruses/HIV</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/697</code>
        <title>obstetrics</title>
        <displayCode>/medical and health sciences/clinical medicine/obstetrics</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-JU-RIA</code>
        <title>HORIZON JU Research and Innovation Actions</title>
        <description>HORIZON JU Research and Innovation Actions</description>
        <displayCode>/HORIZON JU Research and Innovation Actions</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>